Cerus Corporation
General ticker "CERS" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $414.5M (TTM average)
Cerus Corporation follows the US Stock Market performance with the rate: 47.4%.
Estimated limits based on current volatility of 1.7%: low 2.22$, high 2.30$
Factors to consider:
- Total employees count: 275 (-2.1%) as of 2025
- US accounted for 55.2% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Commercialization failure, IFC market acceptance loss, Product liability claims, Capital shortage, Labor/talent shortage/retention
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.74$, 3.26$]
- 2026-12-31 to 2027-12-31 estimated range: [1.92$, 3.50$]
Financial Metrics affecting the CERS estimates:
- Positive: with PPE of -25.8 at the end of fiscal year the price was low
- Negative: Operating cash flow per share per price, % of 1.23 <= 2.37
- Positive: -13.52 < Operating profit margin, % of -3.58
- Positive: -51.61 < Industry operating profit margin (median), % of -29.60
- Positive: 25.20 < Shareholder equity ratio, % of 28.95 <= 34.41
- Positive: Industry inventory ratio change (median), % of 0.70 <= 1.15
- Positive: -7.72 < Return on assets ratio (scaled to [-100,100]) of -6.58
- Negative: 1.42 < Interest expense per share per price, % of 2.12
Short-term CERS quotes
Long-term CERS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $186.80MM | $201.32MM | $233.80MM |
| Operating Expenses | $216.85MM | $215.55MM | $242.48MM |
| Operating Income | $-30.05MM | $-14.22MM | $-8.68MM |
| Non-Operating Income | $-7.27MM | $-6.53MM | $-6.60MM |
| Interest Expense | $8.39MM | $8.88MM | $8.34MM |
| R&D Expense | $67.64MM | $58.91MM | $67.72MM |
| Income(Loss) | $-37.32MM | $-20.76MM | $-15.28MM |
| Taxes | $0.33MM | $0.20MM | $0.35MM |
| Net Income(Loss)* | $-37.49MM | $-20.92MM | $-15.63MM |
| Stockholders Equity | $52.65MM | $56.15MM | $64.22MM |
| Inventory | $39.87MM | $38.15MM | $56.10MM |
| Assets | $197.75MM | $200.92MM | $221.86MM |
| Operating Cash Flow | $-43.17MM | $11.36MM | $4.84MM |
| Capital expenditure | $4.60MM | $2.84MM | $2.84MM |
| Investing Cash Flow | $8.62MM | $-8.13MM | $-6.17MM |
| Financing Cash Flow | $10.67MM | $4.96MM | $0.23MM |
| Earnings Per Share** | $-0.21 | $-0.11 | $-0.08 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.